Overview

AMS VS MOXI Ketek vs Avelox in AMS

Status:
Completed

Trial end date:
2003-09-01

Target enrollment:

Participant gender:

Summary

Clinical efficacy between telithromycin and moxifloxacin at the post-therapy/test of cure visit, and to assess the safety of telithromycin given once daily for 5 days vs moxifloxacin given once daily for 10 days in the treatment of subjects with AMS.

Phase:

Phase 3

Details

Lead Sponsor:

Sanofi

Treatments:

Telithromycin